Published in Eur J Vasc Endovasc Surg on June 15, 2010
Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol (2012) 1.04
Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc (2016) 0.87
The role of nutrition and body composition in peripheral arterial disease. Nat Rev Cardiol (2012) 0.84
Recruiting older patients with peripheral arterial disease: evaluating challenges and strategies. Patient Prefer Adherence (2015) 0.80
Objectively measured physical activity and sedentary behaviour and ankle brachial index: Cross-sectional and longitudinal associations in older men. Atherosclerosis (2016) 0.78
Primary infragenicular angioplasty for diabetic neuroischemic foot ulcers following the angiosome distribution: a new paradigm for the vascular interventionist? Diabetes Metab Syndr Obes (2011) 0.78
Graz Critical Limb Ischemia Score: A Risk Score for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease. Medicine (Baltimore) (2015) 0.75
Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases. Stem Cell Res Ther (2015) 0.75
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17
Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med (1998) 7.18
Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg (2000) 5.50
Oxpentifylline treatment of venous ulcers of the leg. BMJ (1990) 3.75
High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation (2006) 3.48
A simple method for measuring erythrocyte deformability. J Clin Pathol (1976) 2.81
Reduction of polygalacturonase activity in tomato fruit by antisense RNA. Proc Natl Acad Sci U S A (1988) 2.75
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg (1996) 2.48
Impaired red cell deformability in peripheral vascular disease. Lancet (1976) 2.40
Structure and expression of elongation factor 1 alpha in tomato. Nucleic Acids Res (1989) 2.28
Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J (1973) 2.17
Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood (1989) 2.12
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg (2008) 2.10
The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs. J Am Coll Nutr (1998) 2.09
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation (1991) 2.07
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest (1990) 2.07
Leukocytes and the risk of ischemic diseases. JAMA (1987) 2.03
Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed) (1988) 1.85
Clinical significance of blood viscosity. Ann R Coll Surg Engl (1970) 1.75
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation (1995) 1.74
A single amino acid substitution in the enzyme 5-enolpyruvylshikimate-3-phosphate synthase confers resistance to the herbicide glyphosate. J Biol Chem (1985) 1.72
Influence of blood viscosity on blood flow and the effect of low molecular weight dextran. Br Med J (1971) 1.72
Carotid dissection with and without ischemic events: local symptoms and cerebral artery findings. Neurology (2001) 1.71
Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet (1977) 1.67
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation (2001) 1.62
Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int (2006) 1.61
Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am J Hum Genet (2001) 1.58
Identification and characterization of fast-sedimenting SV40 nucleoprotein complexes. Virology (1979) 1.56
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (1990) 1.55
Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol (2001) 1.52
Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology. Vasa (1992) 1.51
Stress arteriography. Lancet (1973) 1.49
Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int (2004) 1.49
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Ann Oncol (2009) 1.47
Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology (1997) 1.47
[The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically?]. Dtsch Med Wochenschr (1996) 1.44
Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol (1985) (1998) 1.43
Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation (1993) 1.43
Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany. Int J Clin Pract (2010) 1.42
Transdermal application of prostaglandin E1 ethyl ester for the treatment of trophic acral skin lesions in a patient with systemic scleroderma. J Eur Acad Dermatol Venereol (2002) 1.42
Hypercoagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg (1997) 1.41
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg (1998) 1.40
Inter-society consensus for the management of peripheral arterial disease. Int Angiol (2007) 1.39
Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J (1973) 1.39
A review of alternative approaches in the management of iatrogenic femoral pseudoaneurysms. Ann R Coll Surg Engl (1999) 1.38
[Low-osmolar gadodiamide as alternative contrast agent for diagnostic angiography and angiographic interventions in patients with renal insufficiency]. Rofo (2002) 1.38
Developmental analysis of elongation factor-1 alpha expression in transgenic tobacco. Plant Cell (1991) 1.37
Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med (2000) 1.33
White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed) (1988) 1.32
Methylation of elongation factor 1 alpha from the fungus Mucor. Proc Natl Acad Sci U S A (1982) 1.30
Abnormal blood viscosity in Raynaud's phenomenon. Lancet (1976) 1.30
Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol (1997) 1.29
Role of fast-sedimenting SV40 nucleoprotein complexes in virus assembly. Virology (1980) 1.28
Haemorrheological response to plasma exchange in Raynaud's syndrome. Br Med J (1979) 1.28
Adventitial cystic disease of the popliteal artery: percutaneous US-guided aspiration. Radiology (1997) 1.24
Transcutaneous oxygen tension during exercise in patients with claudication. Br Med J (Clin Res Ed) (1986) 1.23
Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol Occup Physiol (1999) 1.21
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
Pacing on demand in the treatment of atrioventricular conduction-disturbances of the heart. Lancet (1966) 1.17
Abnormal flow properties of white blood cells in patients with severe ischaemia of the leg. Br Med J (Clin Res Ed) (1988) 1.17
Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. Int Angiol (1999) 1.16
Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology (1993) 1.15
Reliability of ankle:brachial pressure index measurement by junior doctors. Br J Surg (1994) 1.15
Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation (2001) 1.15
Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res (1983) 1.14
Vasomotor reactivity is exhausted in transient ischaemic attacks with limb shaking. J Neurol Neurosurg Psychiatry (1998) 1.13
Accelerated thrombolysis using pulsed intra-thrombus recombinant human tissue type plasminogen activator (rt-PA). Eur J Vasc Surg (1992) 1.13
Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet (1979) 1.12
A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med (2000) 1.12
Preoperative haemoglobin as predictor of outcome of diabetic amputations. Lancet (1979) 1.12
Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) (2003) 1.11
Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc (1995) 1.10
Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis (2008) 1.10
SimpliRED D-dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep vein thrombosis in symptomatic outpatients. Thromb Haemost (1998) 1.08
Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol (2013) 1.06
Clinical outcome and restenosis following percutaneous transluminal angioplasty for ischaemic rest pain or ulceration. Br J Surg (1995) 1.06
Peroperative t-PA thrombolysis. Lancet (1991) 1.05
Role of the 21,000 molecular weight polypeptide of Bacillus subtilis RNA polymerase in RNA synthesis. J Biol Chem (1978) 1.05
Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg (2002) 1.03
Effect of clofibrate on blood viscosity in intermittent claudication. Br Med J (1974) 1.02
Effects of preparative procedures and of cell activation on flow of white cells through micropore filters. Br J Haematol (1988) 1.02
Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease. Circulation (1999) 1.02
Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Pathol (2004) 1.01
Randomised trial of bandaging after sclerotherapy for varicose veins. Br Med J (1980) 0.99
Muscle denervation in peripheral arterial disease. Neurology (1992) 0.99
Innervated myotendinous cylinders in human extraocular muscles. Invest Ophthalmol Vis Sci (2000) 0.98
High blood viscosity: an aetiological factor in venous thrombosis. Br J Surg (1973) 0.98
Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care (1999) 0.98
Oscillometric measurement of ankle-brachial index in patients with suspected peripheral disease: comparison with Doppler method. Swiss Med Wkly (2009) 0.98